NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1467627653 MD
Verify on CMS → Yuanbin Chen, MD
Medical Oncology Physician in Orlando, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 295 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
71%
generic claims · 29% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94/100
▲ 11 pts above national avg 83.5 · Exceptional
Industry payments
$129.3K
221 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Yuanbin Chen, MD reported a CMS MIPS final score of 94/100 - above the 83.5 national average - and filed 1,592 Medicare Part D claims in 2024.
- 94/100
- MIPS score · +11 vs avg
- 2K
- Part D claims, 2024
- 71%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Yuanbin Chen, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1467627653), first enumerated 04/28/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,592 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 94/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$129.3K in reported industry payments (221 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Yuanbin Chen, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1467627653 · Medical Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1467627653
- ENUM-MID 2008
- TAX-NARROW 4,028
- MIPS-ELITE 94/100
- RX-MID 1,592
- BOOK-THIN 318 in Florida
- PHOTO-FINISH Gregory Masters · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Chen · this prov…
Chen · this provider
94 MIPS pts
- Gregory Masters …
Gregory Masters
94 MIPS pts
- Ko Maung · highest
Ko Maung
94.1 MIPS pts
- Laura Kerbin · n…
Laura Kerbin
94.1 MIPS pts
- Magi Khalil · near
Magi Khalil
94.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Yuanbin Chen, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
94 ≥ 73rd percentile 73% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Yuanbin Chen, MD sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Yuanbin Chen, MD writes more Part D claims than 90% of them and scores higher on MIPS quality than 78% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Yuanbin Chen, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Yuanbin Chen, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Yuanbin Chen, MD?
High performer (top quartile)Primary specialty
Medical Oncology Physician
Medicare Part D claims
1,592 117% vs specialty avg
MIPS final score
94/100 10.5 pts vs avg
Specialty distribution in Florida
How Medical Oncology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Yuanbin Chen, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 94/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1467627653 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/28/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.0062
Final Score
Measured-score avg: 83.5
79.3553
Quality
97
Promoting Interoperability
Reporting: Individual
Hospital and facility affiliations
Facilities where Yuanbin Chen, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Cancer And Hematology Centers OF Western MI, P.C.
Grand Rapids, MI
Orlando Health Medical Group Inc
Orlando, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Yuanbin Chen, MD. Source: openpaymentsdata.cms.gov.
Total received
$129.3K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Yuanbin Chen, MD. To verify Yuanbin Chen, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Yuanbin Chen, MD - brand share 29.0%
Medical Oncology Physician average
29% brand-name claims vs 71% generic, on 1,592 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,592
Total Claims
$5.0M
Total Drug Cost
295
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,966.4
- Total Day Supply
- 45,484
- Brand vs Generic
- 29% brand / 71% generic
- Brand Drug Cost
- $4.9M
- Generic Drug Cost
- $53K
- Opioid Claims
- 94 (5.9% rate)
- Antibiotic Claims
- 26
Patient Demographics
- Average Patient Age
- 71.3 years
- Avg HCC Risk Score
- 2.63
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 45, 65-74: 152, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Yuanbin Chen, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prochlorperazine M…
Prochlorperazine Maleate
198 claims
- Tagrisso
Tagrisso
132 claims
- Prednisone
Prednisone
131 claims
- Dexamethasone
Dexamethasone
119 claims
- Levothyroxine Sodium
Levothyroxine Sodium
117 claims
- Olanzapine
Olanzapine
110 claims
- Folic Acid 52
Folic Acid
52 claims
- Hydrocodone-Acetam… 50
Hydrocodone-Acetaminophen
50 claims
| Drug | Claims |
|---|---|
| Prochlorperazine Maleate | 198 |
| Tagrisso Osimertinib Mesylate | 132 |
| Prednisone | 131 |
| Dexamethasone | 119 |
| Levothyroxine Sodium | 117 |
| Olanzapine | 110 |
| Folic Acid | 52 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 50 |
| Mektovi Binimetinib | 46 |
| Braftovi Encorafenib | 43 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Yuanbin Chen, MD fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Yuanbin Chen, MD's 1,592 claims are above the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Chen, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (94 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Chen.
One of 318 Medical Oncology Physician providers enrolled in Florida, 5 are shown here.
Mahmoud Abdelsalam
Gainesville, FL
Dr. Guillermo Abesada-Terk
M.D.
Stuart, FL
Dr. Patrick Acevedo
M.D.
Ocala, FL
Dr. Howard Adler
M.D.
Delray Beach, FL
Dr. Syed Ahmed
M.D.
Sebring, FL
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Yuanbin Chen, MD's specialty? ▼
Yuanbin Chen, MD specializes in Medical Oncology Physician and practices in Orlando, Florida. Credentials: MD.
How much does Yuanbin Chen, MD prescribe under Medicare Part D? ▼
In 2024, Yuanbin Chen, MD wrote 1,592 Medicare Part D claims totaling $5.0M in drug costs for 295 beneficiaries.
What is Yuanbin Chen, MD's Medicare quality score? ▼
Yuanbin Chen, MD has a CMS MIPS Final Score of 94/100 (Quality: 79.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Yuanbin Chen, MD located? ▼
Yuanbin Chen, MD is located at 1400 S ORANGE AVE, Orlando, FL, 32806. Phone: (877) 876-3627.
What is Yuanbin Chen, MD's NPI number? ▼
Yuanbin Chen, MD's National Provider Identifier (NPI) is 1467627653, issued on 04/28/2008.
Does Yuanbin Chen, MD prescribe more brand-name or generic drugs? ▼
Yuanbin Chen, MD's prescribing is 29% brand-name and 71% generic drugs by claim count, with $4.9M in brand drug costs.
Does Yuanbin Chen, MD prescribe opioids? ▼
Yes, Yuanbin Chen, MD had 94 opioid claims in 2024 with an opioid prescribing rate of 5.9%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Yuanbin Chen, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Yuanbin Chen, MD's most frequently prescribed drugs include Prochlorperazine Maleate, Tagrisso, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Yuanbin Chen, MD accept Medicare? ▼
Yuanbin Chen, MD appears in CMS Medicare data with 1,592 Part D claims and 295 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Yuanbin Chen, MD's credentials? ▼
Yuanbin Chen, MD's NPI is 1467627653 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.